http://www.agios.com
Agios Pharmaceuticals, Inc. Company Intro
Industry
Healthcare
Agios Pharmaceuticals, Inc. Headquaters
88 Sidney Street
Cambridge,02139
United States
Agios Pharmaceuticals, Inc. Share price
19 Oct 2020 01:02 GMT
$35.13
-0.04 (-0.11 %)
Agios Pharmaceuticals, Inc. Market cap
$2.479 B
WMC RANKING
2020
Agios Pharmaceuticals, Inc. # 36
BiotechnologyLatest Agios Pharmaceuticals, Inc. News
19 Oct 2020
Relapsed Acute Myeloid Leukemia Drug Market Size, Share ...
... Astellas Pharma Inc., Agios Pharmaceuticals, Inc., AbbVie Inc., Array BioPharma Inc., Actinium Pharmaceuticals, Inc., AstraZeneca Plc, Arog Pharmaceuticals, ...
19 Oct 2020
Agios (AGIO) Withdraws Filing for Leukemia Drug Tibsovo in EU
Agios Pharmaceuticals, Inc. AGIO announced that it has withdrawn the marketing ... In the current year, the company expects Tibsovo sales in the range of ...
19 Oct 2020
Agios Pharmaceuticals Inc. [AGIO] moved up 1.99: Why It's ...
Agios Pharmaceuticals Inc. [NASDAQ: AGIO] jumped around 0.7 points on Friday, while shares priced at $35.87 at the close of the session, up 1.99%.
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Agios Pharmaceuticals, Inc. | 3.16 | 2.65 | 7.35 | 0 | 0 | 0 | 7.33 |
| Alexion Pharmaceuticals, Inc. | 100 | 11.32 | 100 | 20 | 0 | 0 | 96.20 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.68 | 33 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 0 | 0 | 0 | 0.06 |
| Incyte Corporation | 40.27 | 8.70 | 7.11 | 100 | 0 | 0 | 84.84 |
Agios Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Agios Pharmaceuticals, Inc. | $174,783 | $545,309 | $-358,650 | $2.479B | 36 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $27.206B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $56.803B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥20.207B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.821B | 4 |